BridgeBio Pharma, Inc.
-
Ticker
BBIO
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 201-500 Employees
- Based in Palo Alto, California
BridgeBio is a team of experienced drug discoverers, developers and innovators working to create life-altering medicines that target well-characterized genetic diseases at their source. BridgeBio was founded in 2015 to identify and advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers
…More with clear genetic drivers. BridgeBio’s pipeline of over 20 development programs includes product candidates ranging from early discovery to late-stage development.
BridgeBio Pharma, Inc.
Most Recent Responsibility Report
MOST RECENT
2022 Environmental, Social, and Governance Report
Report Locked. BridgeBio Pharma, Inc. has reached its limit for free report views.
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived BridgeBio Pharma, Inc. Sustainability Report, BridgeBio Pharma, Inc. Corporate Social Responsibility Report, BridgeBio Pharma, Inc. CSR Report, BridgeBio Pharma, Inc. Corporate Responsibility, BridgeBio Pharma, Inc. CR Report, BridgeBio Pharma, Inc. Citizenship Report, BridgeBio Pharma, Inc. ESG Report, and BridgeBio Pharma, Inc. Environmental Report online.